FILGOTINIB (Jyseleca®)

Clinical Indication

Moderate to severe arthritis

Comments

In line with NICE TA676

Implementation date 24th May 2021

Date of classification

May 2021

Review date

May 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).